MOG and myeloid sarcoma: Different study groups have developed MRI diagnostic criteria to differentiate MS, from NMOSD and from anti-MOG ab-associated disease, showing 91% sensitivity distinguishing MS from AQP4+ NMOSD, and 95% from anti-MOG ab-associated disease [173,179].